Live Breaking News & Updates on Shyamala Maheswaran

Stay updated with breaking news from Shyamala maheswaran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TellBio Announces Consecutive Manuscripts Showcasing Promising Translational and Clinical Applications of the TellDx Platform in Prostate Cancer and Tailoring Therapy in Advanced Breast Cancer

TellBio Announces Consecutive Manuscripts Showcasing Promising Translational and Clinical Applications of the TellDx Platform in Prostate Cancer and Tailoring Therapy in Advanced Breast Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Daniel Haber , Mehmet Toner , David Miyamoto , Shyamala Maheswaran , Annie Partisano , Priteshj Gandhi , Aditya Bardia , Telldx Technology Demonstrates Efficacy Of Novel Drug , Breast Cancer Research Program , Tellbio Inc , Telldx Technology Demonstrates Epigenetic , Breast Cancer Research , Harvard Medical School , Cancer Research , Hospital Center , Clinical Applications , Telldx Platform , Prostate Cancer , Tailoring Therapy , Advanced Breast , Circulating Tumor Cells Isolated , Telldx Technology Demonstrates Epigenetic Changes , Silence Immune Surveillance Genes , Spare Proliferation Associated , Cancer Cultured Circulating Tumor Cells Derived ,

Circulating Tumor Cell (CTC) Isolation with TellDx

Single-cell proteomics can elucidate kinase activity in prostate cancer models Kinase activity in bone metastases and epithelial circulating. ....

United States , Priteshj Gandhi , Mehmet Toner , Daniela Haber , Shyamala Maheswaran , Annie Partisano , Cancer Research , Tellbio Inc , Hospital Center , Drs David Ting , Massachusetts General Hospital Center ,

TellBio Unveils Next-Generation Liquid Biopsy Platform Focused on Early Detection and Treatment of Cancer

Published: May 10, 2021
Closes $5 million Series A financing
Appoints Pritesh J. Gandhi, PharmD, as Chief Executive Officer and Annie Partisano, PharmD, MS, as Senior Vice President and Head of Operations
Announces exclusive license of TellDx platform to Genetron Holdings Limited for China
Secures Deployment of TellDx at ARUP Laboratories, Inc
BEVERLY, Mass., May 10, 2021 (GLOBE NEWSWIRE)
TellBio, Inc., a development stage biotechnology company focused on revolutionizing the detection and treatment of cancer through its unique and proprietary circulating tumor cell (CTC) technology, TellDx, and complementary therapeutics platform, TellRx, today announced the closing of a $5 million Series A financing. Concurrent with the close, the Company announced the appointments of Pritesh J. Gandhi, PharmD, as Chief Executive Officer (CEO) and Annie Partisano, PharmD, MS, as Senior Vice President and Head of Operations; an exclusive license of the TellDx platf ....

United States , University Of Massachusetts Medical School , Ryo Imai , Sanofi Genzyme , Ravi Kapur , David Ting , Richard Peters , Priteshj Gandhi , Mehmet Toner , Andy Theurer , Shyamala Maheswaran , Annie Partisano , Daniel Haber , University Of Utah , Alnylam Pharmaceuticals , Genetron Holdings , Institute For Clinical , Genetron Holdings Limited , Kiniksa Pharmaceuticals , Affairs At Boehringer Ingelheim , Massachusetts College Of Pharmacy , Laboratories Inc , National Foundation For Cancer Research , Tellbio Inc , Department Of Pathology , Company As Senior Vice ,